logo
Select company
Select metric
$ -618KNet Cash Flow - Change in Cash & Cash Equivalents
VS
Market
44
Sector
51
Industry
54
History
53
$ 1.53Close
$ 0.68 - $ 3.23 52-Week Range
Ticker Information

Ticker

FATE

Company Name

FATE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

FATE THERAPEUTICS INC - Net Cash Flow - Change in Cash & Cash Equivalents Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

FATE - CF - Chg. Cash Historical data
DateNet Cash Flow - Change in Cash & Cash Equivalents
6/30/2025$ -618K
3/31/2025$ -81.35M
12/31/2024$ -10.76M
9/30/2024$ -375K
6/30/2024$ -9.88M
3/31/2024$ 79.25M
12/31/2023$ -19.51M
9/30/2023$ -48.81M
6/30/2023$ -8.52M
3/31/2023$ -22.72M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • FATE THERAPEUTICS INC's latest trailing twelve months (TTM) CF - Chg. Cash stands at $ 114.54M.
  • Over the past 5 years, FATE THERAPEUTICS INC's average CF - Chg. Cash has been $ -34.79M.
  • The median CF - Chg. Cash for FATE THERAPEUTICS INC during this period was $ -20.45M
  • FATE THERAPEUTICS INC reached its highest CF - Chg. Cash over the past 5 years at $ 114.54M.
  • The lowest CF - Chg. Cash recorded by FATE THERAPEUTICS INC in the same timeframe $ -356.42M

FATE THERAPEUTICS INC's CF - Chg. Cash vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

CF - Chg. Cash Benchmarks
CompanyCF - Chg. Cash
CRVO : CERVOMED INC $ -1.69MTCRX : TSCAN THERAPEUTICS INC $ -72.77MCUE : CUE BIOPHARMA INC $ -2.54MSRZN : SURROZEN INC $ 52.63MKRRO : KORRO BIO INC $ -59.31MOVID : OVID THERAPEUTICS INC $ -1.28MACOG : ALPHA COGNITION INC $ 38.27MARMP : ARMATA PHARMACEUTICALS INC $ -22.17MCBUS : CIBUS INC $ 6.44MCRBU : CARIBOU BIOSCIENCES INC $ -12.66M

Definition of Net Cash Flow - Change in Cash & Cash Equivalents

[Cash Flow Statement] Represents the amount of increase (decrease) in cash and cash equivalents. Includes cash from operations [NCFO], investing [NCFI] and financing [NCFF], adjusted for the effect of exchange rate changes on cash [NCFX]

FATE - Net Cash Flow - Change in Cash & Cash Equivalents, Last 5 years

$ -356.42M

Minimum

Jun 30, 2021

$ 114.54M

Maximum

Sep 30, 2020

$ -34.79M

Average

$ -20.45M

Median

CF - Chg. Cash Benchmark Analysis

The chart above depicts the distribution of CF - Chg. Cash for companies in the Total Stock Market. The average CF - Chg. Cash of the companies is $ 1.17M with a standard deviation of $ 44.93M.
The following table provides additional summary stats:
CF - Chg. Cash in the Market:
filtered constituents3.34K
min$ -136.09M
max$ 137.58M
average$ 1.17M
median$ 115.89K
std$ 44.93M